Nike stock has fallen to levels investors haven’t seen in more than a decade, and the company’s latest earnings report has raised fresh questions about whether its long-awaited turnaround is actually working. Shares of Nike (NYSE: NKE) closed at $34.36 on October 7, 2026, following a volatile stretch that included a sharp post-earnings selloff and only a modest recovery. During early trading on October 8, the stock was quoted around $34.19, approximately 0.5% below the previous close. The weakness comes after Nike reported declining revenue, disappointing guidance and continued pressure across important parts of its global business.
For investors following the Nike stock forecast 2026, the situation has become unusually complicated. Nike remains one of the most recognizable brands in the world, yet its shares have lost much of the premium investors once assigned to its growth potential. The stock is now trading dramatically below its historical highs, but management expects sales to decline further during fiscal 2027, and Wall Street has responded with increasingly cautious price targets. The central question is whether Nike’s depressed share price already reflects the worst of its problems or whether investors are still underestimating how long the recovery could take.
Nike Stock’s Latest Decline Shows How Quickly Investor Confidence Has Deteriorated
Nike’s recent trading history illustrates the market’s growing frustration. The stock closed at $35.84 on September 29, slipped to $35.40 the following day and finished October 1 at $35.15. Selling accelerated on October 2, when shares dropped 3.64% to $33.87 after investors digested the company’s earnings announcement and cautious outlook. The stock briefly traded as low as $31.97 that day, establishing an important reference point for investors attempting to identify potential support.
A modest rebound followed, with Nike closing at $33.96 on October 5 and $34.61 on October 6, before slipping back to $34.36 on October 7. The sequence left shares approximately 4.1% below their September 29 closing level, confirming that the recovery had not yet reversed the broader selling pressure. Although the rebound from the October 2 intraday low suggests some investors are willing to buy at depressed prices, the inability to sustain upward momentum indicates that confidence remains fragile.
The significance extends beyond a handful of trading sessions. Nike has moved from being valued as a dominant global growth company to being treated primarily as a turnaround investment. That change in perception matters because investors are no longer willing to pay a premium simply for the strength of the Swoosh. They want evidence that management can restore revenue growth, defend market share and rebuild earnings.
Related articles
Nike’s Latest Earnings Exposed a Bigger Problem Than Wall Street Expected
Nike’s fiscal 2027 first-quarter results, released on October 1, provided the clearest explanation for the stock’s weakness. Revenue declined 4% to approximately $11.2 billion, while diluted earnings per share reached $0.48. Gross margin improved by 60 basis points to 42.8%, offering some evidence that the company’s efforts to reduce promotional pressure and improve its product mix are producing results. However, Nike Direct revenue declined 8%, demonstrating that the company’s direct-to-consumer business continues to struggle despite management’s attempts to restore demand.
The most damaging announcement was management’s full-year outlook. Nike expects fiscal 2027 revenue to decline by a high-single-digit percentage, while adjusted earnings per share are projected between $1.15 and $1.35. Those figures indicate that the company’s recovery is likely to remain uneven, with further pressure on sales and profitability before any meaningful improvement becomes visible. For investors who had hoped Nike was approaching a clear turning point, the guidance was a reminder that rebuilding a global consumer brand’s growth momentum can take considerably longer than expected.
The contrast between improving gross margin and declining revenue is particularly important. Nike may be becoming more disciplined about discounts and inventory, but those improvements will have limited impact on the investment case if consumers continue buying fewer products. Sustainable earnings growth ultimately requires a combination of stronger demand, healthier pricing and operating efficiency rather than relying on cost reductions alone.
China and Nike Direct Are Becoming the Biggest Obstacles to Recovery
Two areas remain particularly difficult for Nike: Greater China and its direct-to-consumer operations. China was once one of the company’s most promising growth markets, supported by rising consumer spending and strong demand for international athletic brands. More recently, Nike has faced weaker demand, more cautious consumers and intensifying competition from domestic companies that have improved their products and marketing. The resulting pressure has made it harder for Nike to rely on China as a source of growth while its North American business undergoes restructuring.
Nike Direct presents a different but equally important challenge. The company’s previous strategy emphasized selling more products through its own stores and digital channels, an approach intended to improve margins and strengthen customer relationships. However, reducing its presence with traditional wholesale partners created opportunities for competitors to capture shelf space and build relationships with consumers. CEO Elliott Hill has been working to reverse that imbalance by rebuilding wholesale distribution while attempting to make Nike’s direct channels more effective.
The difficulty is that repairing distribution relationships does not automatically restore demand. Retailers have developed stronger connections with competing brands, while consumers have become increasingly willing to experiment with alternatives. Nike must therefore demonstrate that its product innovation can generate renewed excitement rather than simply placing more merchandise in stores.
The $2.5 Billion Restructuring Plan Could Help—but Investors Must Be Patient
Management is attempting to address the company’s problems through its Pace restructuring initiative, which targets approximately $2.5 billion in cumulative savings through fiscal 2031. The program is intended to simplify operations, improve productivity and create financial capacity for investment in innovation and marketing. In principle, these measures could strengthen Nike’s profitability once revenue begins recovering, particularly if management can reduce unnecessary complexity without weakening the company’s ability to develop and distribute compelling products.
However, the timeline matters. Savings spread across several fiscal years cannot immediately compensate for a significant decline in annual revenue, and restructuring initiatives often require upfront investment before their full benefits become visible. Nike also needs to avoid cutting too deeply into the areas that made the brand successful, including product development, athlete partnerships and marketing. A turnaround built exclusively on lower expenses would risk leaving the company more efficient but less competitive.
For shareholders, the key question is whether Nike can use the savings to support renewed growth rather than merely offsetting continued weakness. If restructuring produces healthier margins while innovative products begin attracting consumers again, the financial benefits could become substantial. If sales continue declining, the savings may simply slow the deterioration in earnings.
Wall Street’s Nike Stock Price Targets Reveal a Deeply Divided Market
Analyst expectations have become increasingly cautious following Nike’s latest results. According to Stock Analysis, the consensus of 42 analysts places the average 12-month price target at approximately $38.15, representing about 11% upside from the October 7 closing price of $34.36. The consensus recommendation is Hold, suggesting that Wall Street generally recognizes Nike’s long-term brand strength but remains reluctant to assume a rapid operational recovery.
Individual forecasts reveal an even wider disagreement. BNP Paribas has issued a $19 target, implying substantial downside, while Morgan Stanley has targeted $27 and Berenberg $27.50. Goldman Sachs has set a $30 target, UBS $34 and Barclays $37. At the optimistic end, Guggenheim’s $50 target suggests the possibility of a much stronger rebound if management begins delivering convincing evidence of improvement.
These forecasts should not be interpreted as guaranteed future prices, but they illustrate the uncertainty surrounding Nike’s earnings trajectory. The bearish analysts appear concerned that weak demand, competition and disappointing guidance could keep pressure on profitability, while more optimistic forecasts assume that Nike’s brand strength and restructuring initiatives will eventually restore growth.
The disagreement is particularly meaningful because the stock’s current price leaves relatively little room for another major disappointment, yet the valuation is not as inexpensive as the historical decline might suggest.
Nike Stock Looks Cheap Compared With Its Past—but Earnings Tell a Different Story
At approximately $34 per share, Nike trades dramatically below the levels investors were accustomed to during its strongest growth years. That decline naturally makes the stock appear attractive to bargain hunters, especially given the company’s global recognition, extensive distribution network and longstanding relationships with elite athletes. However, comparing today’s share price with historical highs can be misleading because Nike’s expected earnings have also deteriorated.
Using management’s fiscal 2027 adjusted earnings guidance of $1.15–$1.35 per share, the stock trades at approximately 25–30 times expected adjusted earnings. That is a substantial valuation for a company forecasting a high-single-digit revenue decline, particularly when investors can find businesses with stronger near-term growth elsewhere in the market. Nike’s valuation therefore depends heavily on the expectation that current earnings represent a temporary low point rather than a permanently weaker level of profitability.
If management eventually restores sales growth and improves margins, the company’s earnings power could recover significantly, making today’s share price appear attractive in hindsight. But if competition continues eroding market share or the turnaround takes longer than expected, the stock could remain under pressure even without another dramatic decline in reported results.
Where Could Nike Stock Go Next? Three Scenarios Investors Should Consider
Nike’s recent trading range provides several useful reference points for evaluating potential outcomes. The $31.97 intraday low reached on October 2 is an important near-term support level because it marks the point where buyers previously stepped in after the earnings-driven selloff. A sustained move below that area could encourage additional selling, while a recovery above approximately $35–$36 would suggest that short-term sentiment is beginning to improve. A stronger rebound toward $38–$40 would require more convincing evidence that earnings expectations are stabilizing.
In a bearish scenario, Nike could trade between $25 and $30 over the next six to twelve months if revenue continues declining, China remains weak and management struggles to protect profitability. That range would be broadly consistent with some of Wall Street’s more cautious price targets and would reflect a market increasingly concerned about the duration of the turnaround.
A more balanced scenario places Nike between $32 and $40, assuming that sales gradually stabilize without an immediate return to strong growth. Under those conditions, the stock could remain volatile as investors weigh improving operational efficiency against persistent demand challenges. This appears to be a reasonable central scenario based on the company’s current guidance and the relatively cautious analyst consensus.
A bullish scenario would see shares recovering toward $45–$50 if Nike begins demonstrating stronger product demand, improving performance in China and a more convincing earnings recovery. Such an outcome is possible given the company’s brand strength and historical profitability, but it would require meaningful operational improvement rather than simply a temporary change in investor sentiment. These ranges are illustrative scenarios, not guaranteed forecasts or probability-weighted price targets.
The Nike Stock Forecast 2026 Depends on Whether Elliott Hill Can Deliver Real Growth
Nike’s recent decline has brought the stock to a critical point in its turnaround. Shares closed at $34.36 on October 7, after a volatile stretch that included a fall to $31.97 and only a limited rebound. The latest earnings confirmed that revenue remains under pressure, Nike Direct is shrinking and management expects a high-single-digit decline in fiscal 2027 sales. Those developments explain why analysts have reduced their expectations and why the stock continues trading near historically depressed levels.
At the same time, Nike retains important advantages. Its brand remains globally recognized, its distribution network is enormous, and its restructuring program could eventually strengthen profitability. Gross-margin improvement in the latest quarter provides an early indication that some operational changes are working, although stronger demand will be necessary to transform those improvements into sustainable earnings growth.
The next several quarters will determine whether the stock is approaching a durable bottom or simply experiencing another pause in a longer decline. Investors should focus on Greater China sales, Nike Direct performance, gross margins, new product launches and any changes to management’s fiscal 2027 outlook. Nike’s upcoming investor event in November may also provide important insight into Elliott Hill’s expectations for the pace of recovery.
The most reasonable near-term outlook is cautious rather than aggressively bullish. A recovery toward $38–$40 is plausible if business conditions stabilize, but a sustained move toward $50 would require evidence that Nike’s earnings trajectory is improving. Conversely, continued sales weakness could bring the recent $31.97 low back into focus.
Nike stock is now cheap compared with its historical share price, but that does not automatically make it inexpensive relative to future profits. The company still has the brand, resources and global reach to recover. What investors are waiting for is proof that those advantages can translate into growth again.
And until Elliott Hill delivers that evidence, the question surrounding Nike stock will remain the same: is $34 the beginning of a recovery—or merely another stop on the way down?
Disclaimer
This article is for informational purposes only and does not constitute financial or investment advice. Readers should conduct their own research and, where appropriate, consult a qualified financial advisor before making investment decisions. This article was researched and drafted with the support of AI, but it has not yet undergone independent editorial review; all figures and claims should be fact-checked before publication.
